Patent ID: 8236335

Claim:
A method for treating a subject with a microbial infection comprising administering a nanoemulsion, or a dilution thereof, to said subject, wherein said administering is via a route selected from the group consisting of intradermal injection, subcutaneous injection, intramuscular injection, intraperitoneal injection, orally, nasally, buccally, rectally, vaginally, topically, and by inhalation, wherein said nanoemulsion comprises: 1. 30-90%, 60-80%, or 60-70% by volume oil; 2. 3-15% by volume solvent; wherein said solvent is selected from the group consisting of ethanol and glycerol; 3. 3-15% by volume surfactant; wherein said surfactant is selected from the group consisting of polyoxyethylenesorbitan monolaurate and polyoxyethylenesorbitan monooleate; and 4. water; and wherein said microbial infection is selected from the group consisting of microbial infection with a bacteria, microbial infection with a virus, and microbial infection with a fungus.